These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 8103792)

  • 21. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS 7056: a novel ultra-short-acting Benzodiazepine.
    Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
    Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes.
    Tang AH; Smith MW; Carter DB; Im WB; VonVoigtlander PF
    J Pharmacol Exp Ther; 1995 Nov; 275(2):761-7. PubMed ID: 7473164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test.
    Mathiasen LS; Rodgers RJ; Mirza NR
    Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
    Serra M; Ghiani CA; Motzo C; Cuccheddu T; Floris S; Giusti P; Biggio G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):32-8. PubMed ID: 8169838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological activity of novel alkylsulfonylaryl-1-substituted-1,4-benzodiazepine derivatives.
    Pérez C; Mondelo N; Stéfano FJ; Lores Arnaiz J
    Arch Int Pharmacodyn Ther; 1988; 293():57-68. PubMed ID: 2901826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
    Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
    J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
    Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE; Simiand J; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action.
    Giusti P; Guidetti G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1062-8. PubMed ID: 1675286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic characterization of a novel non-benzodiazepine selective anxiolytic, DN-2327.
    Wada T; Nakajima R; Kurihara E; Narumi S; Masuoka Y; Goto G; Saji Y; Fukuda N
    Jpn J Pharmacol; 1989 Mar; 49(3):337-49. PubMed ID: 2568511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
    Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
    Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.
    Ozawa M; Nakada Y; Sugimachi K; Yabuuchi F; Akai T; Mizuta E; Kuno S; Yamaguchi M
    Jpn J Pharmacol; 1994 Mar; 64(3):179-87. PubMed ID: 7912751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.